UK Biobanking Showcase 2017 The annual UK Biobanking Showcase was held on 18th October, 2017 at the Kia Oval cricket ground in London. Over 140 people attended the event, covering human sample resources across the country, universities, medical funders and different medical companies and organisations. This year’s showcase sought to highlight some of the recent[…]
Representing UK-based biobanking at Global Biobank Week Presentation slide from the ‘DNA, Your Say’ project This week, our Engagement Manager Jessica Mai Sims reports her experience at Global Biobank Week. Global Biobank Week was held in Stockholm this in September 2017. This year the conference was hosted as a collaboration between BBMRI-ERIC, ESBB and ISBER.[…]
ISO Biobank Standards Assuring researchers as to the quality or standard of a Biobank is an important issue. We are here to keep you abreast of all the latest developments in the field. You may have heard that new ISO Biobank standards are coming soon, but who is writing them and how can you get[…]
Services available for new BBMRI.uk network The UKCRC TDCC is the UK’s node within BBRMI-ERIC; we can also, therefore, be referred to as BBMRI.uk. This membership means we are part of a much larger European effort and as a result the services BBMRI develop are available to UK Biobanks. We are initiating our own BBMRI.uk[…]
The UKCRC TDCC reports on a workshop on the use of human tissue for safety assessment jointly hosted by the Safety Pharmacology Society, the University of Coventry and NC3Rs.
Patient data and tissue samples – benefits, barriers and concerns On 9th May, 2017, the UKCRC TDCC co-hosted the workshop ‘Patient data and tissue samples – benefits, barriers and concerns’ along with Use MY Data<, Independent Cancer Patient’s Voice (ICPV) and the NCRI’s Cellular & Molecular Pathology (CM-Path) initiative. The event was a good opportunity[…]
Many Biobanks are under pressure to adopt more sustainable, business-like mentalities in the future. The results of a ISBER survey on business planning in the Biobanking community is outlined in this post.
A recent study has found that only around 9% of biobanks have a publicly available access policy. Given that most biobanks are funded by the public, there is an expectation that the samples they contain are made available for external research purposes that could ultimately have a social benefit. But for this to happen, clear[…]